Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
22133
CAS Number:
25316-40-9
Clorhidrato de doxorrubicina
Grade:
Cumple con las especificaciones USP
Purity:
98 - 102% (ensayo, en base anhidra)
Synonym(s):
Clorhidrato de hidroxidaunorrubicina, Clorhidrato de adriamicina
Documents
$35.00 /25 mg
Tamaño
Request Bulk Quote
Información del producto

Doxorubicin hydrochloride is a potent anthracycline antibiotic widely utilized in oncology for its effective anti-cancer properties. This compound is primarily used in the treatment of various cancers, including breast cancer, bladder cancer, and leukemia, owing to its ability to intercalate DNA and inhibit topoisomerase II, leading to apoptosis in rapidly dividing cells. Its unique structure allows for enhanced cellular uptake, making it a critical component in combination chemotherapy regimens.

In addition to its therapeutic applications, Doxorubicin hydrochloride is also being explored in research settings for its potential in targeted drug delivery systems and nanomedicine, where its cytotoxic effects can be harnessed in a more controlled manner. The compound's versatility and effectiveness make it a valuable asset in both clinical and research environments, providing significant benefits in cancer treatment protocols and innovative therapeutic strategies.

Número CAS
25316-40-9
Fórmula molecular
C27H29NO11 · HCl
Peso molecular
579.98
Número MDL
MFCD00077757
Rotación óptica
[a]D20 = 240 - 290°
Condiciones
Conservar entre 0 y 8 °C.
Información general
Número CAS
25316-40-9
Fórmula molecular
C27H29NO11 · HCl
Peso molecular
579.98
Número MDL
MFCD00077757
Rotación óptica
[a]D20 = 240 - 290°
Condiciones
Conservar entre 0 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Doxorubicin hydrochloride is widely utilized in research focused on

  • Cancer Treatment: This compound is a cornerstone in chemotherapy regimens for various cancers, including breast, lung, and leukemia. Its ability to intercalate DNA helps inhibit cancer cell growth effectively.
  • Combination Therapies: It is often used in combination with other anticancer drugs to enhance therapeutic efficacy and reduce the likelihood of drug resistance, providing a more comprehensive treatment approach.
  • Research in Drug Development: Doxorubicin hydrochloride serves as a model compound in the development of new anticancer agents, allowing researchers to study mechanisms of action and improve drug formulations.
  • Targeted Drug Delivery Systems: Researchers are exploring its use in nanotechnology, where it can be encapsulated in nanoparticles for targeted delivery, minimizing side effects and maximizing drug concentration at tumor sites.
  • Cardiotoxicity Studies: Due to its known side effects, it is frequently used in studies aimed at understanding and mitigating cardiotoxicity, helping to develop safer treatment protocols for patients.

Citas